RIBC2
geneOn this page
Also known as DKFZp566F0546FLJ25720
Summary
RIBC2 (RIB43A domain with coiled-coils 2, HGNC:13241) is a protein-coding gene on chromosome 22q13.31, encoding RIB43A-like with coiled-coils protein 2 (Q9H4K1). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Predicted to be involved in flagellated sperm motility. Located in axonemal microtubule.
Source: NCBI Gene 26150 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 25 total
- MANE Select transcript:
NM_015653
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13241 |
| Approved symbol | RIBC2 |
| Name | RIB43A domain with coiled-coils 2 |
| Location | 22q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp566F0546, FLJ25720 |
| Ensembl gene | ENSG00000128408 |
| Ensembl biotype | protein_coding |
| OMIM | 621115 |
| Entrez | 26150 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 1 protein_coding_CDS_not_defined, 1 protein_coding, 1 retained_intron
ENST00000466226, ENST00000614167, ENST00000621287
RefSeq mRNA: 1 — MANE Select: NM_015653
NM_015653
CCDS: CCDS14066
Canonical transcript exons
ENST00000614167 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003712373 | 45432284 | 45432509 |
| ENSE00003730468 | 45425948 | 45426175 |
| ENSE00003732033 | 45413693 | 45414015 |
| ENSE00003733145 | 45414322 | 45414403 |
| ENSE00003737017 | 45417602 | 45417946 |
| ENSE00003737226 | 45422290 | 45422408 |
| ENSE00003749600 | 45430900 | 45431066 |
Expression profiles
Bgee: expression breadth ubiquitous, 175 present calls, max score 93.32.
FANTOM5 (CAGE): breadth broad, TPM avg 2.5543 / max 100.1409, expressed in 804 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 192718 | 2.5543 | 804 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 93.32 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 92.87 | gold quality |
| right uterine tube | UBERON:0001302 | 91.87 | gold quality |
| bronchus | UBERON:0002185 | 91.57 | gold quality |
| left testis | UBERON:0004533 | 88.71 | gold quality |
| right testis | UBERON:0004534 | 88.69 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.49 | gold quality |
| testis | UBERON:0000473 | 86.72 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.09 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 85.55 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 85.37 | silver quality |
| adult organism | UBERON:0007023 | 82.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 82.76 | gold quality |
| ventricular zone | UBERON:0003053 | 77.36 | gold quality |
| endometrium epithelium | UBERON:0004811 | 77.35 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 76.07 | silver quality |
| sperm | CL:0000019 | 73.04 | silver quality |
| male germ cell | CL:0000015 | 72.38 | silver quality |
| ganglionic eminence | UBERON:0004023 | 71.43 | gold quality |
| adenohypophysis | UBERON:0002196 | 70.20 | gold quality |
| pituitary gland | UBERON:0000007 | 69.96 | gold quality |
| fallopian tube | UBERON:0003889 | 69.77 | gold quality |
| frontal pole | UBERON:0002795 | 68.47 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 67.83 | gold quality |
| stromal cell of endometrium | CL:0002255 | 66.79 | gold quality |
| paraflocculus | UBERON:0005351 | 66.02 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 65.77 | gold quality |
| oviduct epithelium | UBERON:0004804 | 64.76 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 64.69 | gold quality |
| rectum | UBERON:0001052 | 64.27 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 11.29 |
| E-ANND-3 | yes | 4.84 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- A common variant rs2272804 in the 5’UTR of RIBC2 inhibits downstream gene expression by creating an upstream open reading frame. (PMID:32329860)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ribc2 | ENSDARG00000075177 |
| mus_musculus | Ribc2 | ENSMUSG00000022431 |
| rattus_norvegicus | Ribc2 | ENSRNOG00000033502 |
| drosophila_melanogaster | CG7264 | FBGN0036214 |
Paralogs (1): RIBC1 (ENSG00000158423)
Protein
Protein identifiers
RIB43A-like with coiled-coils protein 2 — Q9H4K1 (reviewed: Q9H4K1)
All UniProt accessions (1): Q9H4K1
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme.
Tissue specificity. Expressed in airway epithelial cells.
Similarity. Belongs to the RIB43A family.
RefSeq proteins (1): NP_056468* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008805 | RIB43A | Family |
Pfam: PF05914
UniProt features (5 total): sequence variant 3, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7UNG | ELECTRON MICROSCOPY | 3.6 |
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H4K1-F1 | 86.88 | 0.49 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 107 (showing top):
MODULE_52, YAGI_AML_WITH_INV_16_TRANSLOCATION, MODULE_16, CAGCTG_AP4_Q5, MODULE_118, MODULE_379, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, DOANE_RESPONSE_TO_ANDROGEN_DN, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GNF2_CCNA1, SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP, MODULE_88, MODULE_242, GATA4_Q3
GO Biological Process (1): flagellated sperm motility (GO:0030317)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (9): nucleus (GO:0005634), axonemal microtubule (GO:0005879), sperm flagellum (GO:0036126), axonemal A tubule inner sheath (GO:0160111), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| 9+2 motile cilium | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
1845 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RIBC2 | TRIB1 | Q96RU8 | 930 |
| RIBC2 | TRIB3 | Q96RU7 | 920 |
| RIBC2 | TRIB2 | Q92519 | 901 |
| RIBC2 | MAP2K1 | Q02750 | 768 |
| RIBC2 | COP1 | Q8NHY2 | 715 |
| RIBC2 | MAP2K4 | P45985 | 662 |
| RIBC2 | CEP15 | Q9HBI5 | 528 |
| RIBC2 | J3KS56 | J3KS56 | 522 |
| RIBC2 | AKT1 | P31749 | 513 |
| RIBC2 | MAP2K7 | O14733 | 494 |
| RIBC2 | STK40 | Q8N2I9 | 490 |
| RIBC2 | CCDC150 | Q8NCX0 | 489 |
| RIBC2 | FAM217B | Q9NTX9 | 475 |
| RIBC2 | CCDC77 | Q9BR77 | 473 |
| RIBC2 | CFAP36 | Q96G28 | 460 |
IntAct
38 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| YBX1 | HNRNPR | psi-mi:“MI:0914”(association) | 0.770 |
| RIBC2 | LRP2 | psi-mi:“MI:0915”(physical association) | 0.590 |
| RIBC2 | tax | psi-mi:“MI:0915”(physical association) | 0.560 |
| RIBC2 | GFAP | psi-mi:“MI:0915”(physical association) | 0.550 |
| RIBC2 | RAD54B | psi-mi:“MI:0915”(physical association) | 0.550 |
| GFAP | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.550 |
| RAD54B | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.550 |
| YBX1 | HNRNPL | psi-mi:“MI:0914”(association) | 0.530 |
| RIBC2 | psi-mi:“MI:0915”(physical association) | 0.490 | |
| RIBC2 | psi-mi:“MI:0915”(physical association) | 0.490 | |
| RIBC2 | SNRPA1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TRIM23 | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RIBC2 | GTPBP3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RIBC2 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RIBC2 | BEGAIN | psi-mi:“MI:0915”(physical association) | 0.370 |
| MTUS2 | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRIM37 | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ATRIP | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RIBC2 | TEX11 | psi-mi:“MI:0915”(physical association) | 0.370 |
| JUP | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRAF2 | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RIBC2 | EFEMP2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CCDC85B | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NINL | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RIBC2 | NRBP1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KRT15 | RIBC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RIBC2 | HOOK2 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (30): RIBC2 (Two-hybrid), GTPBP3 (Two-hybrid), USHBP1 (Two-hybrid), BEGAIN (Two-hybrid), RIBC2 (Two-hybrid), RIBC2 (Two-hybrid), RIBC2 (Two-hybrid), TEX11 (Two-hybrid), RIBC2 (Two-hybrid), RIBC2 (Two-hybrid), EFEMP2 (Two-hybrid), RIBC2 (Two-hybrid), RIBC2 (Two-hybrid), NRBP1 (Two-hybrid), RIBC2 (Two-hybrid)
ESM2 similar proteins: A0A0R4IFG5, A0A480NP79, A0A974E306, A0AUP1, A0AUT1, A0JLY1, A4IJ21, A7S8T5, A8I9E8, D6REC4, E1BJL9, F1N7G5, O88346, P02641, Q0VC09, Q0VFZ6, Q1RM03, Q2KIQ2, Q2TA16, Q32KY1, Q32LJ7, Q32LN4, Q3TVW5, Q3USS3, Q4R698, Q4R7T8, Q4R8R3, Q5RE49, Q61884, Q6AXN9, Q6AXQ8, Q6AYL4, Q6PBA8, Q7T0Y4, Q7TNB2, Q7Z4T9, Q8BRC6, Q8N443, Q8NEF3, Q8NEH6
Diamond homologs: Q0VC09, Q32LJ7, Q4R698, Q6AXN9, Q6AYL4, Q8N443, Q9D0B8, Q9D4Q1, Q9H4K1
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 33 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Dengue Virus-Host Interactions | 6 | 11.9× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
25 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1242 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:45413955:G:GT | donor_gain | 1.0000 |
| 22:45414006:GA:G | donor_gain | 1.0000 |
| 22:45414007:A:T | donor_gain | 1.0000 |
| 22:45414314:A:AG | acceptor_gain | 1.0000 |
| 22:45414315:T:G | acceptor_gain | 1.0000 |
| 22:45414318:ATAG:A | acceptor_gain | 1.0000 |
| 22:45414318:ATAGG:A | acceptor_gain | 1.0000 |
| 22:45414319:T:G | acceptor_gain | 1.0000 |
| 22:45414319:TAGGG:T | acceptor_gain | 1.0000 |
| 22:45414320:A:AG | acceptor_gain | 1.0000 |
| 22:45414320:AG:A | acceptor_gain | 1.0000 |
| 22:45414320:AGG:A | acceptor_gain | 1.0000 |
| 22:45414320:AGGGA:A | acceptor_gain | 1.0000 |
| 22:45414321:G:GA | acceptor_gain | 1.0000 |
| 22:45414321:GG:G | acceptor_gain | 1.0000 |
| 22:45414321:GGG:G | acceptor_gain | 1.0000 |
| 22:45414321:GGGA:G | acceptor_gain | 1.0000 |
| 22:45414321:GGGAG:G | acceptor_gain | 1.0000 |
| 22:45414399:CTTTG:C | donor_gain | 1.0000 |
| 22:45414400:TTTG:T | donor_gain | 1.0000 |
| 22:45414401:TTG:T | donor_gain | 1.0000 |
| 22:45414401:TTGG:T | donor_loss | 1.0000 |
| 22:45414403:GGTGA:G | donor_loss | 1.0000 |
| 22:45414404:G:A | donor_loss | 1.0000 |
| 22:45414404:G:GG | donor_gain | 1.0000 |
| 22:45414405:T:G | donor_loss | 1.0000 |
| 22:45422288:A:AG | acceptor_gain | 1.0000 |
| 22:45422289:G:GG | acceptor_gain | 1.0000 |
| 22:45422289:GA:G | acceptor_gain | 1.0000 |
| 22:45426167:G:GT | donor_gain | 1.0000 |
AlphaMissense
2559 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:45417733:T:C | F115L | 0.963 |
| 22:45417735:T:A | F115L | 0.963 |
| 22:45417735:T:G | F115L | 0.963 |
| 22:45432342:T:C | F377L | 0.961 |
| 22:45432344:T:A | F377L | 0.961 |
| 22:45432344:T:G | F377L | 0.961 |
| 22:45417694:T:C | F102L | 0.916 |
| 22:45417696:C:A | F102L | 0.916 |
| 22:45417696:C:G | F102L | 0.916 |
| 22:45426104:T:A | W278R | 0.910 |
| 22:45426104:T:C | W278R | 0.910 |
| 22:45417889:T:A | W167R | 0.903 |
| 22:45417889:T:C | W167R | 0.903 |
| 22:45417878:A:C | Q163P | 0.898 |
| 22:45417858:G:C | R156S | 0.896 |
| 22:45417858:G:T | R156S | 0.896 |
| 22:45432333:T:C | F374L | 0.891 |
| 22:45432335:C:A | F374L | 0.891 |
| 22:45432335:C:G | F374L | 0.891 |
| 22:45417826:T:C | F146L | 0.879 |
| 22:45417828:C:A | F146L | 0.879 |
| 22:45417828:C:G | F146L | 0.879 |
| 22:45413989:T:C | F35L | 0.878 |
| 22:45413991:C:A | F35L | 0.878 |
| 22:45413991:C:G | F35L | 0.878 |
| 22:45426109:G:C | K279N | 0.872 |
| 22:45426109:G:T | K279N | 0.872 |
| 22:45417902:A:C | Q171P | 0.862 |
| 22:45417840:T:A | D150E | 0.859 |
| 22:45417840:T:G | D150E | 0.859 |
dbSNP variants (sampled 300 via entrez): RS1000327589 (22:45430254 G>T), RS1000386655 (22:45412437 G>T), RS1000663125 (22:45431543 A>G), RS1000715237 (22:45431744 C>G,T), RS1000848677 (22:45415589 T>G), RS1000887595 (22:45421043 CTG>C), RS1000977090 (22:45420752 C>T), RS1001264933 (22:45426072 C>A,T), RS1001383491 (22:45429277 A>G), RS1001473461 (22:45413134 C>T), RS1001573210 (22:45423766 T>C), RS1001809153 (22:45418489 C>G), RS1001871175 (22:45424900 C>G,T), RS1001942325 (22:45418298 A>C), RS1001979640 (22:45419544 G>C)
Disease associations
OMIM: gene MIM:621115 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008151_93 | Waist circumference | 8.000000e-07 |
| GCST008160_93 | Waist circumference | 8.000000e-07 |
| GCST011946_16 | White matter hyperintensity volume | 6.000000e-06 |
| GCST011947_18 | White matter hyperintensity volume | 1.000000e-06 |
| GCST011949_32 | White matter hyperintensity volume (adjusted for hypertension) | 7.000000e-06 |
| GCST011950_8 | White matter hyperintensity volume (adjusted for hypertension) | 1.000000e-06 |
| GCST011953_18 | White matter hyperintensity volume x hypertension interaction (2df) | 6.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005665 | white matter hyperintensity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects methylation, affects splicing, decreases expression, increases expression | 5 |
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| GSK-J4 | decreases expression | 1 |
| afuresertib | decreases expression | 1 |
| sotorasib | affects cotreatment, increases expression | 1 |
| bisphenol A | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| abrine | decreases expression | 1 |
| licochalcone B | decreases expression | 1 |
| trametinib | increases expression, affects cotreatment | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| NVP-BKM120 | increases expression, affects cotreatment | 1 |
| Resveratrol | increases expression, affects cotreatment | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases expression, increases abundance | 1 |
| Cisplatin | increases expression | 1 |
| Coumestrol | affects cotreatment, increases expression | 1 |
| Endosulfan | affects cotreatment, increases expression | 1 |
| Oxygen | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tetrachlorodibenzodioxin | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Zearalenone | decreases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hypertensive disorder